Clinical Trial Update: Assessment of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Various Formulations and Doses of PWT-143 [Phase 1]

View source ↗

Summary

This Phase 1 trial assessed safety, tolerability, pharmacokinetics, and pharmacodynamics of various formulations and doses of the investigational drug PWT-143 i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• PWT-143 (PWT-143)

Snippet

Sponsor: MEI Pharma, Inc. | Conditions: Malignancies | Phase 1 | Status: COMPLETED